首页> 外文OA文献 >A systematic review and meta-Analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem- resistant pseudomonas aeruginosa
【2h】

A systematic review and meta-Analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem- resistant pseudomonas aeruginosa

机译:系统评价和荟萃分析表明,使用碳青霉烯和医疗器械是耐药的铜绿假单胞菌的主要危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

textabstractA systematic review and meta-Analyses were performed to identify the risk factors associated with carbapenem-resistant Pseudomonas aeruginosa and to identify sources and reservoirs for the pathogen. A systematic search of PubMed and Embase databases from 1 January 1987 until 27 January 2012 identified 1,662 articles, 53 of which were included in a systematic review and 38 in a random-effects meta-Analysis study. The use of carbapenem, use of fluoroquinolones, use of vancomycin, use of other antibiotics, having medical devices, intensive care unit (ICU) admission, having underlying diseases, patient characteristics, and length of hospital stay were significant risk factors in multivariate analyses. The meta-Analyses showed that carbapenem use (odds ratio [OR]=7.09; 95% confidence interval [CI]=5.43 to 9.25) and medical devices (ORμ5.11; 95% CIμ3.55 to 7.37) generated the highest pooled estimates. Cumulative meta-Analyses showed that the pooled estimate of carbapenem use was stable and that the pooled estimate of the risk factor "having medical devices" increased with time. We conclude that our results highlight the importance of antibiotic stewardship and the thoughtful use of medical devices in helping prevent outbreaks of carbapenem-resistant P. aeruginosa.
机译:进行了系统的回顾和荟萃分析,以确定与耐碳青霉烯的铜绿假单胞菌相关的危险因素,并确定病原体的来源和储库。从1987年1月1日至2012年1月27日,系统搜索PubMed和Embase数据库,确定了1,662篇文章,其中53篇纳入系统评价,38篇纳入随机效应荟萃分析研究。碳青霉烯的使用,氟喹诺酮类的使用,万古霉素的使用,其他抗生素的使用,具有医疗设备,重症监护病房(ICU)的入院,潜在疾病,患者特征和住院时间是多因素分析中的重要危险因素。荟萃分析显示,碳青霉烯的使用(赔率[OR] = 7.09; 95%置信区间[CI] = 5.43至9.25)和医疗设备(ORμ5.11; 95%CIμ3.55至7.37)产生了最高的合并估计值。累积荟萃分析显示,碳青霉烯类药物使用的合并评估是稳定的,并且“具有医疗器械”风险因素的合并评估随时间增加。我们得出的结论是,我们的结果突出了抗生素管理的重要性以及医疗设备的精心使用在帮助预防对碳青霉烯耐药的铜绿假单胞菌暴发中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号